Avoiding 483 Observations and Warning Letters 2012

  • 17 Oct 2012
  • Webinar

Description

Avoiding 483 Observations and Warning Letters 2012 is a webinar that covers topics such as:

  • Recent news headlines - prominent / respected company failures
  • The "tougher" U. S. FDA and Regulatory "Hot Buttons"
  • Address Problems With an Eye to the Future
  • Why do Companies Fail When They Are in Compliance
  • Filling in the "Gaps"
  • Reviewing Company Compliance to These Issues
  • Entropy - a major "player"

Avoiding 483 Observations and Warning Letters 2012 brings together QA, Senior management in Drugs, Devices, Biologics, Dietary Supplements, R&D, RA, Production, Engineering, Consultants others tasked with product, process, validations, cGMP responsibilities and Operations.

Past Events

Important

Please, check "Avoiding 483 Observations and Warning Letters" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Medical device, Medical laboratories, Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions